Found: 11
Select item for more details and to access through your institution.
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours.
- Published in:
- 2015
- By:
- Publication type:
- journal article
HER2 Positivity in Histological Subtypes of Salivary Gland Carcinoma: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.693394
- By:
- Publication type:
- Article
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.
- Published in:
- Frontiers in Genetics, 2023, v. 14, p. 1, doi. 10.3389/fgene.2023.1058605
- By:
- Publication type:
- Article
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Patients in phase 1 cancer trials: psychological distress and understanding of trial information.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 3, p. 341, doi. 10.1080/0284186X.2021.1993331
- By:
- Publication type:
- Article
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.
- Published in:
- Clinical Laboratory, 2017, n. 10, p. 1755, doi. 10.7754/Clin.Lab.2017.170516
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1065, doi. 10.1007/s00280-015-2728-5
- By:
- Publication type:
- Article
Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 10, p. 2145, doi. 10.1002/ijc.34420
- By:
- Publication type:
- Article
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 7, p. 1007, doi. 10.1093/neuonc/nov019
- By:
- Publication type:
- Article